Norsk Hydro
24.6.2026 08:00:00 CEST | Globenewswire | Press release
Norsk Hydro: Invitation to Hydro's second quarter results 2026
Norsk Hydro: Invitation to Hydro's second quarter results 2026
Hydro's second quarter results 2026 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on July 22, 2026. The quarterly report and presentation will be available on hydro.com at the same time as the release.
President and CEO Eivind Kallevik, and Executive Vice President and CFO Trond Olaf Christophersen, will host a webinar in English at 08:30 CEST the same day. A Q&A session will follow directly after the presentation. There will be no physical presentation or press conference.
To join the webinar and ask questions, please use the link to the webcast page.
The webcast is powered by Zoom. No login or advance registration is required.
It is also possible to join the conference using the dial-in option:
Norway +47 2400 4736
London, UK +44 330 088 5830
New York, US +1 929 205 6099
Meeting ID: 935 7810 1684
We advise you to check in advance whether your company has any restrictions on using the Zoom platform.
Investor contact:
Baard Erik Haugen
+47 92497191
erik.haugen@hydro.com
Valentina Gandolfi
+47 95882355
Valentina.gandolfi@hydro.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
DSV A/S28.7.2026 15:06:53 CEST | Press release
DSV, 1172 - MANAGER'S TRANSACTIONS IN DSV A/S SHARES
HERE Enterprise Inc.28.7.2026 15:00:00 CEST | Press release
HERE Expands Enterprise Browser Security with Integrated Threat Detection and Response from Keep Aware
LyondellBasell28.7.2026 15:00:00 CEST | Press release
Chemical Marketing & Economics honors LyondellBasell CEO Peter Vanacker with STEM Leadership Award for Corporate Reinvention
ProLogium Technology Co., Ltd.28.7.2026 15:00:00 CEST | Press release
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
AGC Biologics, Inc.28.7.2026 14:59:00 CEST | Press release
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom